Michaela Marschmann

Minimizing DILI risk in drug discovery — A screening tool for drug candidates

Simone Schadt, Silke Simon, Stefan Kustermann et al. · Toxicology in Vitro · 2015 · 88 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Post‐acquisition analysis of untargeted accurate mass quadrupole time‐of‐flight MS ^E data for multiple collision‐induced neutral losses and fragment ions of glutathione conjugates

Andreas Brink, Fabien Fontaine, Michaela Marschmann et al. · Rapid Communications in Mass Spectrometry · 2014 · 42 citations

Medicine, Biochemistry, Pharmacology +17

Simultaneous Assessment of Clearance, Metabolism, Induction, and Drug-Drug Interaction Potential Using a Long-Term In Vitro Liver Model for a Novel Hepatitis B Virus Inhibitor

Nicole A. Kratochwil, Miriam Triyatni, Martina B. Mueller et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 13 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Comparative analysis of adherence, viability, proliferation and morphology of umbilical cord tissue-derived mesenchymal stem cells seeded on different titanium-coated expanded polytetrafluoroethylene scaffolds

Trixi Hollweck, Michaela Marschmann, Isabel Hartmann et al. · Biomedical Materials · 2010 · 11 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +16